๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Study of deterioration in long-term treatment of parkinsonism with L-Dopa plus decarboxylase inhibitor

โœ Scribed by H. P. Ludin; F. Bass-Verrey


Publisher
Springer
Year
1976
Tongue
English
Weight
602 KB
Volume
38
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Comparative study of selegiline plus L-d
โœ Timothy Brannan; Dr. Melvin D. Yahr ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 383 KB ๐Ÿ‘ 1 views

The long-term effect of selegiline (L-deprenyl) in the treatment of Parkinson's disease has not been clearly delineated. We report on a group of patients whose treatment was initiated with selegiline (n = 43) and then subsequently included L-dopa-carbidopa (Sinemet) and in whom an extended period o

Long-term benefits of rivastigmine in de
โœ Werner Poewe; Erik Wolters; Murat Emre; Marco Onofrj; Chuanchieh Hsu; Sibel Teki ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 110 KB

## Abstract In patients with dementia associated with Parkinson's disease (PD), the efficacy and safety of rivastigmine, an inhibitor of acetylcholinesterase and butyrylcholinesterase, were previously demonstrated in a 24โ€week doubleโ€blind placeboโ€controlled trial. Our objective was to determine wh